ClinicalTrials.Veeva

Menu

Study of Low Carbohydrate Enteral Nutrition in Patients With Bacterial Septic Shock

Yale University logo

Yale University

Status

Withdrawn

Conditions

Bacterial Sepsis

Treatments

Dietary Supplement: low-carbohydrate nutrition
Dietary Supplement: Standard enteral nutrition

Study type

Interventional

Funder types

Other

Identifiers

NCT03343041
2000021424

Details and patient eligibility

About

This pilot study aims to test the tolerability of low-carbohydrate enteral nutrition in patients with bacterial septic shock.

Full description

This study seeks to assess the tolerability of utilizing low-carbohydrate nutrition in patients admitted to the MICU with bacterial septic shock. Low carbohydrate feeds have been used before in the critical care setting and were well-tolerated.

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients aged 18-65 admitted to the MICU with a diagnosis of severe sepsis or septic shock
  2. Patients with 35 > BMI > 18.5
  3. Patients with serum pro-calcitonin > 1 ng/mL in the first 24 hours of hospitalization

Exclusion criteria

  1. Patients with chronic kidney disease as defined by glomerular filtration rate < 60 for > 6 months
  2. Patients with chronic liver disease as defined by radiographic or tissue evidence of cirrhosis or persistently abnormal liver function tests for > 6 months
  3. Patients with current malignancies
  4. Patients with autoimmune disease on current immunotherapy
  5. Patients on corticosteroids at doses of prednisone or prednisone-equivalents > 5 mg for > 6 months
  6. Patients with weight-reduction surgeries
  7. Patients with positive viral studies in the first 24 hours of admission

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 2 patient groups

low carbohydrate nutrition
Active Comparator group
Description:
We will use a low-carbohydrate nutrition (LCN) formulated by the MICU registered dietitian and pharmacy staff, who routinely prepare enteral and parenteral nutrition which will provide: 5% carb, 41% protein, 54% lipid.
Treatment:
Dietary Supplement: low-carbohydrate nutrition
standard enteral nutrition
Active Comparator group
Description:
The standard enteral nutrition (SEN) and per cent contribution of carbohydrates used in the Yale MICU is as follows: Jevity 1.2 56% carb, 29.5% lipid, 18.5% protein Diabetisource 33% carb, 44% lipid, 20% protein Promote 55% carb, 25% lipid, 25% protein Vital AF 37% carb, 40% lipid, 25% protein Peptamin Intense 29% carb, 34% lipid, 37% protein Osmolite 1.5 54% carb, 29.5% lipid, 16.5% protein
Treatment:
Dietary Supplement: Standard enteral nutrition

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems